Calbee, Inc. (CBCFF)
OTCMKTS · Delayed Price · Currency is USD
23.00
+2.48 (12.11%)
At close: Sep 4, 2024
Theseus Pharmaceuticals Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
| 327,142 | 322,564 | 303,027 | 279,315 | 245,419 | 266,745 | Upgrade | |
Revenue Growth (YoY) | 6.38% | 6.45% | 8.49% | 13.81% | -7.99% | 4.22% | Upgrade |
Cost of Revenue | 218,401 | 212,686 | 201,068 | 189,115 | 161,465 | 148,935 | Upgrade |
Gross Profit | 108,741 | 109,878 | 101,959 | 90,200 | 83,954 | 117,810 | Upgrade |
Selling, General & Admin | 81,998 | 80,755 | 74,654 | 67,868 | 58,793 | 90,746 | Upgrade |
Operating Expenses | 82,124 | 80,884 | 74,800 | 68,079 | 58,917 | 90,885 | Upgrade |
Operating Income | 26,617 | 28,994 | 27,159 | 22,121 | 25,037 | 26,925 | Upgrade |
Interest Expense | -362 | -357 | -250 | -162 | -99 | -100 | Upgrade |
Interest & Investment Income | 1,017 | 1,052 | 488 | 179 | 123 | 131 | Upgrade |
Earnings From Equity Investments | 20 | 16 | 17 | 24 | 19 | -104 | Upgrade |
Currency Exchange Gain (Loss) | -1,886 | -203 | 3,509 | 1,125 | 1,712 | 452 | Upgrade |
Other Non Operating Income (Expenses) | 345 | 342 | 232 | 172 | 146 | 216 | Upgrade |
EBT Excluding Unusual Items | 25,751 | 29,844 | 31,155 | 23,459 | 26,938 | 27,520 | Upgrade |
Gain (Loss) on Sale of Investments | 70 | 25 | 163 | 54 | -7 | 207 | Upgrade |
Gain (Loss) on Sale of Assets | -82 | -78 | -353 | -21 | -17 | -43 | Upgrade |
Asset Writedown | -482 | -454 | -749 | -1,101 | -407 | -559 | Upgrade |
Other Unusual Items | 62 | 60 | -12 | 249 | 240 | -745 | Upgrade |
Pretax Income | 25,319 | 29,397 | 30,204 | 22,640 | 26,747 | 26,380 | Upgrade |
Income Tax Expense | 7,650 | 7,892 | 9,739 | 7,667 | 8,470 | 8,315 | Upgrade |
Earnings From Continuing Operations | 17,669 | 21,505 | 20,465 | 14,973 | 18,277 | 18,065 | Upgrade |
Minority Interest in Earnings | -321 | -631 | -579 | -201 | -224 | -383 | Upgrade |
Net Income | 17,348 | 20,874 | 19,886 | 14,772 | 18,053 | 17,682 | Upgrade |
Net Income to Common | 17,348 | 20,874 | 19,886 | 14,772 | 18,053 | 17,682 | Upgrade |
Net Income Growth | -16.21% | 4.97% | 34.62% | -18.17% | 2.10% | 0.81% | Upgrade |
Shares Outstanding (Basic) | 125 | 125 | 125 | 128 | 133 | 134 | Upgrade |
Shares Outstanding (Diluted) | 125 | 125 | 125 | 128 | 133 | 134 | Upgrade |
Shares Change (YoY) | 0.04% | 0.01% | -2.63% | -3.19% | -0.86% | -0.02% | Upgrade |
EPS (Basic) | 138.86 | 167.10 | 159.22 | 115.16 | 136.25 | 132.30 | Upgrade |
EPS (Diluted) | 138.86 | 167.10 | 159.22 | 115.16 | 136.25 | 132.30 | Upgrade |
EPS Growth | -16.24% | 4.95% | 38.26% | -15.48% | 2.98% | 0.83% | Upgrade |
Free Cash Flow | 15,183 | 10,994 | -6,241 | -6,440 | 9,836 | 19,735 | Upgrade |
Free Cash Flow Per Share | 121.53 | 88.01 | -49.97 | -50.20 | 74.23 | 147.66 | Upgrade |
Dividend Per Share | 58.000 | 58.000 | 56.000 | 52.000 | 52.000 | 50.000 | Upgrade |
Dividend Growth | 3.57% | 3.57% | 7.69% | - | 4.00% | - | Upgrade |
Gross Margin | - | 34.06% | 33.65% | 32.29% | 34.21% | 44.17% | Upgrade |
Operating Margin | 8.14% | 8.99% | 8.96% | 7.92% | 10.20% | 10.09% | Upgrade |
Profit Margin | 5.30% | 6.47% | 6.56% | 5.29% | 7.36% | 6.63% | Upgrade |
Free Cash Flow Margin | 4.64% | 3.41% | -2.06% | -2.31% | 4.01% | 7.40% | Upgrade |
EBITDA | 41,774 | 43,290 | 39,834 | 34,147 | 36,045 | 37,729 | Upgrade |
EBITDA Margin | - | 13.42% | 13.15% | 12.22% | 14.69% | 14.14% | Upgrade |
D&A For EBITDA | 15,157 | 14,296 | 12,675 | 12,026 | 11,008 | 10,804 | Upgrade |
EBIT | 26,617 | 28,994 | 27,159 | 22,121 | 25,037 | 26,925 | Upgrade |
EBIT Margin | - | 8.99% | 8.96% | 7.92% | 10.20% | 10.09% | Upgrade |
Effective Tax Rate | - | 26.85% | 32.24% | 33.87% | 31.67% | 31.52% | Upgrade |
Advertising Expenses | - | 12,577 | 10,783 | 8,956 | 6,512 | 39,840 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.